Knockdown of METTL1 or WDR4 reduces m7G‐modified tRNAs and suppresses tumor growth, making m7G a key driver and potential therapeutic target in ESCC.[45]. The gene discussed is METTL1; the disease is esophageal squamous cell carcinoma.